Многолетняя совместная работа научных сообществ над первыми Клиническими рекомендациями по сепсису увенчалась успехом! 17 декабря Клинические рекомендации одобрены Научно-практическим советом Министерства здравоохранения РФ
Array ( [NAME] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» [~NAME] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» [PREVIEW_PICTURE] => Array ( [ID] => 3031 [TIMESTAMP_X] => 30.04.2020 19:40:13 [MODULE_ID] => iblock [HEIGHT] => 3264 [WIDTH] => 4928 [FILE_SIZE] => 4898790 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/0dd [FILE_NAME] => Depositphotos_75531177_xl-2015.jpg [ORIGINAL_NAME] => Depositphotos_75531177_xl-2015.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => e2f481797c8c650f88e9a3e07dbb680e [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/0dd/Depositphotos_75531177_xl-2015.jpg [UNSAFE_SRC] => /upload/iblock/0dd/Depositphotos_75531177_xl-2015.jpg [SAFE_SRC] => /upload/iblock/0dd/Depositphotos_75531177_xl-2015.jpg [ALT] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» [TITLE] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» ) [~PREVIEW_PICTURE] => 3031 [DETAIL_TEXT] =>
[~DETAIL_TEXT] =>Инфекции представляют серьезную угрозу как жизни одного человека, так и человечеству в целом. Открытие антибиотиков позволило спасти миллионы людей. Вместе с тем, широкое применение АБ препаратов привело к формированию устойчивости к ним у целого ряда микроорганизмов.
Антибиотикорезистентность в настоящий момент приобрела глобальный характер . Во время вебинара были представлены проблемы терапии инфекций у одной из наиболее сложных категорий больных- онкологических. Були показаны особенности инфекций у этой категории пациентов, принципы управления антимикробной резистентностью в стационаре, возможности современных АБ препаратов и их правильное использование.
Вебинар предназначен для широкой аудитории врачей- клинических фармакологов, реаниматологов, онкологов, хирургов, терапевтов.
Модераторы вебинара:
Кулабухов Владимир Витальевич - ведущий научный сотрудник ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ» к.м.н., доцентЕпифанова Наталья Юрьевна - доктор медицинских наук, заведующая отделением клинической фармакологии «Национального медицинского исследовательского центра онкологии им Н.Н. Блохина»
Вебинар проходил 14 мая в 15:00
Свои вопросы вы сможете задать, направив их по адресу vkulabukhov@me.com
Посмотреть запись Вы можете по ссылке: https://youtu.be/-317GjkyEUA
[DETAIL_PICTURE] => [~DETAIL_PICTURE] => [DATE_ACTIVE_FROM] => 14.05.2020 [~DATE_ACTIVE_FROM] => 14.05.2020 [ACTIVE_FROM_X] => 2020-05-14 00:00:00 [~ACTIVE_FROM_X] => 2020-05-14 00:00:00 [ACTIVE_FROM] => 14.05.2020 [~ACTIVE_FROM] => 14.05.2020 [SHOW_COUNTER] => 541 [~SHOW_COUNTER] => 541 [ID] => 7853 [~ID] => 7853 [IBLOCK_ID] => 2 [~IBLOCK_ID] => 2 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [DETAIL_TEXT_TYPE] => html [~DETAIL_TEXT_TYPE] => html [PREVIEW_TEXT] => [~PREVIEW_TEXT] => [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [TIMESTAMP_X] => 30.05.2020 12:09:48 [~TIMESTAMP_X] => 30.05.2020 12:09:48 [LIST_PAGE_URL] => /library/articles/ [~LIST_PAGE_URL] => /library/articles/ [DETAIL_PAGE_URL] => /library/articles/formirovanie-protokolov-empiricheskoy-antimikrobnoy-terapii-kak-osnovy-upravleniya-antimikrobnoy-rez/ [~DETAIL_PAGE_URL] => /library/articles/formirovanie-protokolov-empiricheskoy-antimikrobnoy-terapii-kak-osnovy-upravleniya-antimikrobnoy-rez/ [LANG_DIR] => / [~LANG_DIR] => / [CODE] => formirovanie-protokolov-empiricheskoy-antimikrobnoy-terapii-kak-osnovy-upravleniya-antimikrobnoy-rez [~CODE] => formirovanie-protokolov-empiricheskoy-antimikrobnoy-terapii-kak-osnovy-upravleniya-antimikrobnoy-rez [EXTERNAL_ID] => 7853 [~EXTERNAL_ID] => 7853 [IBLOCK_TYPE_ID] => articles [~IBLOCK_TYPE_ID] => articles [IBLOCK_CODE] => articles [~IBLOCK_CODE] => articles [IBLOCK_EXTERNAL_ID] => content-articles [~IBLOCK_EXTERNAL_ID] => content-articles [LID] => s1 [~LID] => s1 [NAV_RESULT] => [NAV_CACHED_DATA] => [DISPLAY_ACTIVE_FROM] => 14 мая 2020 [IPROPERTY_VALUES] => Array ( ) [FIELDS] => Array ( [NAME] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» [PREVIEW_PICTURE] => Array ( [ID] => 3031 [TIMESTAMP_X] => 30.04.2020 19:40:13 [MODULE_ID] => iblock [HEIGHT] => 3264 [WIDTH] => 4928 [FILE_SIZE] => 4898790 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/0dd [FILE_NAME] => Depositphotos_75531177_xl-2015.jpg [ORIGINAL_NAME] => Depositphotos_75531177_xl-2015.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => e2f481797c8c650f88e9a3e07dbb680e [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/0dd/Depositphotos_75531177_xl-2015.jpg [UNSAFE_SRC] => /upload/iblock/0dd/Depositphotos_75531177_xl-2015.jpg [SAFE_SRC] => /upload/iblock/0dd/Depositphotos_75531177_xl-2015.jpg [ALT] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» [TITLE] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» ) [DETAIL_TEXT] =>Инфекции представляют серьезную угрозу как жизни одного человека, так и человечеству в целом. Открытие антибиотиков позволило спасти миллионы людей. Вместе с тем, широкое применение АБ препаратов привело к формированию устойчивости к ним у целого ряда микроорганизмов.
Антибиотикорезистентность в настоящий момент приобрела глобальный характер . Во время вебинара были представлены проблемы терапии инфекций у одной из наиболее сложных категорий больных- онкологических. Були показаны особенности инфекций у этой категории пациентов, принципы управления антимикробной резистентностью в стационаре, возможности современных АБ препаратов и их правильное использование.
Вебинар предназначен для широкой аудитории врачей- клинических фармакологов, реаниматологов, онкологов, хирургов, терапевтов.
Модераторы вебинара:
Кулабухов Владимир Витальевич - ведущий научный сотрудник ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ» к.м.н., доцентЕпифанова Наталья Юрьевна - доктор медицинских наук, заведующая отделением клинической фармакологии «Национального медицинского исследовательского центра онкологии им Н.Н. Блохина»
Вебинар проходил 14 мая в 15:00
Свои вопросы вы сможете задать, направив их по адресу vkulabukhov@me.com
Посмотреть запись Вы можете по ссылке: https://youtu.be/-317GjkyEUA
[DETAIL_PICTURE] => [DATE_ACTIVE_FROM] => 14.05.2020 [ACTIVE_FROM] => 14.05.2020 [SHOW_COUNTER] => 541 ) [PROPERTIES] => Array ( [KEYWORDS] => Array ( [ID] => 1 [TIMESTAMP_X] => 2017-07-31 16:04:44 [IBLOCK_ID] => 2 [NAME] => Ключевые слова [ACTIVE] => Y [SORT] => 100 [CODE] => KEYWORDS [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 102 [FILE_TYPE] => jpg, gif, bmp, png, jpeg [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Ключевые слова [~DEFAULT_VALUE] => ) [DESCRIPTION] => Array ( [ID] => 64 [TIMESTAMP_X] => 2017-08-02 11:16:15 [IBLOCK_ID] => 2 [NAME] => Описание [ACTIVE] => Y [SORT] => 200 [CODE] => DESCRIPTION [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Описание [~DEFAULT_VALUE] => ) [BROWSER_TITLE] => Array ( [ID] => 9 [TIMESTAMP_X] => 2017-08-02 11:18:27 [IBLOCK_ID] => 2 [NAME] => Заголовок окна браузера [ACTIVE] => Y [SORT] => 300 [CODE] => BROWSER_TITLE [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => content-articles-property-browser_title [FILE_TYPE] => [MULTIPLE_CNT] => 1 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => Y [FILTRABLE] => Y [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Заголовок окна браузера [~DEFAULT_VALUE] => ) [MAIN] => Array ( [ID] => 65 [TIMESTAMP_X] => 2017-08-02 11:18:51 [IBLOCK_ID] => 2 [NAME] => Показывать на главной странице [ACTIVE] => Y [SORT] => 500 [CODE] => MAIN [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 815945 [VALUE] => да [DESCRIPTION] => [VALUE_ENUM] => да [VALUE_XML_ID] => Y [VALUE_SORT] => 500 [VALUE_ENUM_ID] => 1 [~VALUE] => да [~DESCRIPTION] => [~NAME] => Показывать на главной странице [~DEFAULT_VALUE] => ) [vote_count] => Array ( [ID] => 100 [TIMESTAMP_X] => 2017-08-29 13:04:27 [IBLOCK_ID] => 2 [NAME] => Количество проголосовавших [ACTIVE] => Y [SORT] => 500 [CODE] => vote_count [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 823539 [VALUE] => 5 [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 5 [~DESCRIPTION] => [~NAME] => Количество проголосовавших [~DEFAULT_VALUE] => ) [vote_sum] => Array ( [ID] => 101 [TIMESTAMP_X] => 2017-08-29 13:04:27 [IBLOCK_ID] => 2 [NAME] => Сумма оценок [ACTIVE] => Y [SORT] => 500 [CODE] => vote_sum [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 823540 [VALUE] => 22 [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 22 [~DESCRIPTION] => [~NAME] => Сумма оценок [~DEFAULT_VALUE] => ) [rating] => Array ( [ID] => 102 [TIMESTAMP_X] => 2017-08-29 13:04:27 [IBLOCK_ID] => 2 [NAME] => Рейтинг [ACTIVE] => Y [SORT] => 500 [CODE] => rating [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 823541 [VALUE] => 4.4 [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 4.4 [~DESCRIPTION] => [~NAME] => Рейтинг [~DEFAULT_VALUE] => ) [FAVORITES] => Array ( [ID] => 148 [TIMESTAMP_X] => 2017-09-15 12:05:50 [IBLOCK_ID] => 2 [NAME] => Избранное [ACTIVE] => Y [SORT] => 500 [CODE] => FAVORITES [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => UserID [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Избранное [~DEFAULT_VALUE] => ) [LIKE] => Array ( [ID] => 153 [TIMESTAMP_X] => 2017-09-19 10:40:01 [IBLOCK_ID] => 2 [NAME] => Понравилось [ACTIVE] => Y [SORT] => 500 [CODE] => LIKE [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => UserID [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Понравилось [~DEFAULT_VALUE] => ) [SUBTITLE] => Array ( [ID] => 93 [TIMESTAMP_X] => 2017-08-22 15:43:39 [IBLOCK_ID] => 2 [NAME] => Подзаголовок [ACTIVE] => Y [SORT] => 501 [CODE] => SUBTITLE [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Подзаголовок [~DEFAULT_VALUE] => ) [AUTHOR] => Array ( [ID] => 94 [TIMESTAMP_X] => 2017-09-07 12:12:40 [IBLOCK_ID] => 2 [NAME] => Автор [ACTIVE] => Y [SORT] => 502 [CODE] => AUTHOR [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 1 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => Y [VERSION] => 1 [USER_TYPE] => UserID [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 815672 ) [VALUE] => Array ( [0] => 8 ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => 8 ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Автор [~DEFAULT_VALUE] => ) [QUOTE] => Array ( [ID] => 95 [TIMESTAMP_X] => 2017-08-22 16:30:23 [IBLOCK_ID] => 2 [NAME] => Цитата [ACTIVE] => Y [SORT] => 503 [CODE] => QUOTE [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Цитата [~DEFAULT_VALUE] => ) [SLIDER] => Array ( [ID] => 98 [TIMESTAMP_X] => 2017-08-23 13:50:37 [IBLOCK_ID] => 2 [NAME] => Слайдер [ACTIVE] => Y [SORT] => 503 [CODE] => SLIDER [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => jpg, gif, bmp, png, jpeg [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Слайдер [~DEFAULT_VALUE] => ) [SLIDER_DESC] => Array ( [ID] => 99 [TIMESTAMP_X] => 2017-08-23 13:50:37 [IBLOCK_ID] => 2 [NAME] => Слайдер описание [ACTIVE] => Y [SORT] => 503 [CODE] => SLIDER_DESC [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Слайдер описание [~DEFAULT_VALUE] => ) [INFO_SOURCES] => Array ( [ID] => 96 [TIMESTAMP_X] => 2017-08-23 10:51:22 [IBLOCK_ID] => 2 [NAME] => Информация и источники [ACTIVE] => Y [SORT] => 504 [CODE] => INFO_SOURCES [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 1 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Информация и источники [~DEFAULT_VALUE] => ) [MATERIALS] => Array ( [ID] => 97 [TIMESTAMP_X] => 2017-08-23 11:05:12 [IBLOCK_ID] => 2 [NAME] => Материалы к статье [ACTIVE] => Y [SORT] => 505 [CODE] => MATERIALS [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Материалы к статье [~DEFAULT_VALUE] => ) [SUBJECTS] => Array ( [ID] => 66 [TIMESTAMP_X] => 2017-09-07 12:12:40 [IBLOCK_ID] => 2 [NAME] => Тематика [ACTIVE] => Y [SORT] => 1000 [CODE] => SUBJECTS [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => Y [VERSION] => 1 [USER_TYPE] => directory [USER_TYPE_SETTINGS] => Array ( [size] => 1 [width] => 0 [group] => N [multiple] => N [TABLE_NAME] => b_hlbd_subjects ) [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 815671 ) [VALUE] => Array ( [0] => Дискуссия ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => Дискуссия ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Тематика [~DEFAULT_VALUE] => ) [COMMENTS_COUNT] => Array ( [ID] => 103 [TIMESTAMP_X] => 2017-08-29 13:04:27 [IBLOCK_ID] => 2 [NAME] => Количество комментариев [ACTIVE] => Y [SORT] => 5010 [CODE] => COMMENTS_COUNT [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Количество комментариев [~DEFAULT_VALUE] => ) [FB2] => Array ( [ID] => 173 [TIMESTAMP_X] => 2017-10-12 14:43:36 [IBLOCK_ID] => 2 [NAME] => FB2 [ACTIVE] => Y [SORT] => 5020 [CODE] => FB2 [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => fb2 [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => FB2 [~DEFAULT_VALUE] => ) [ADD_DATES] => Array ( [ID] => 207 [TIMESTAMP_X] => 2018-05-11 11:01:14 [IBLOCK_ID] => 2 [NAME] => Дата добавления материалов [ACTIVE] => Y [SORT] => 5030 [CODE] => ADD_DATES [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => Date [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Дата добавления материалов [~DEFAULT_VALUE] => ) [LENGHT] => [VIDEO_PREVIEW] => [VIDEO_FULL] => ) [DISPLAY_PROPERTIES] => Array ( [MAIN] => Array ( [ID] => 65 [TIMESTAMP_X] => 2017-08-02 11:18:51 [IBLOCK_ID] => 2 [NAME] => Показывать на главной странице [ACTIVE] => Y [SORT] => 500 [CODE] => MAIN [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 815945 [VALUE] => да [DESCRIPTION] => [VALUE_ENUM] => да [VALUE_XML_ID] => Y [VALUE_SORT] => 500 [VALUE_ENUM_ID] => 1 [~VALUE] => да [~DESCRIPTION] => [~NAME] => Показывать на главной странице [~DEFAULT_VALUE] => [DISPLAY_VALUE] => да ) [rating] => Array ( [ID] => 102 [TIMESTAMP_X] => 2017-08-29 13:04:27 [IBLOCK_ID] => 2 [NAME] => Рейтинг [ACTIVE] => Y [SORT] => 500 [CODE] => rating [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 823541 [VALUE] => 4.4 [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 4.4 [~DESCRIPTION] => [~NAME] => Рейтинг [~DEFAULT_VALUE] => [DISPLAY_VALUE] => 4.4 ) [AUTHOR] => Array ( [ID] => 94 [TIMESTAMP_X] => 2017-09-07 12:12:40 [IBLOCK_ID] => 2 [NAME] => Автор [ACTIVE] => Y [SORT] => 502 [CODE] => AUTHOR [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 1 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => Y [VERSION] => 1 [USER_TYPE] => UserID [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 815672 ) [VALUE] => Array ( [0] => 8 ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => 8 ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Автор [~DEFAULT_VALUE] => [DISPLAY_VALUE] => [8] (info@sepsisforum.ru) Команда Сепсис Форума ) [SUBJECTS] => Array ( [ID] => 66 [TIMESTAMP_X] => 2017-09-07 12:12:40 [IBLOCK_ID] => 2 [NAME] => Тематика [ACTIVE] => Y [SORT] => 1000 [CODE] => SUBJECTS [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => Y [VERSION] => 1 [USER_TYPE] => directory [USER_TYPE_SETTINGS] => Array ( [size] => 1 [width] => 0 [group] => N [multiple] => N [TABLE_NAME] => b_hlbd_subjects ) [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 815671 ) [VALUE] => Array ( [0] => Дискуссия ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => Дискуссия ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Тематика [~DEFAULT_VALUE] => [DISPLAY_VALUE] => Дискуссия ) ) [IBLOCK] => Array ( [ID] => 2 [~ID] => 2 [TIMESTAMP_X] => 26.08.2022 14:38:28 [~TIMESTAMP_X] => 26.08.2022 14:38:28 [IBLOCK_TYPE_ID] => articles [~IBLOCK_TYPE_ID] => articles [LID] => s1 [~LID] => s1 [CODE] => articles [~CODE] => articles [API_CODE] => [~API_CODE] => [NAME] => Статьи [~NAME] => Статьи [ACTIVE] => Y [~ACTIVE] => Y [SORT] => 200 [~SORT] => 200 [LIST_PAGE_URL] => /library/articles/ [~LIST_PAGE_URL] => /library/articles/ [DETAIL_PAGE_URL] => /library/articles/#ELEMENT_CODE#/ [~DETAIL_PAGE_URL] => /library/articles/#ELEMENT_CODE#/ [SECTION_PAGE_URL] => /articles/#SECTION_CODE#/ [~SECTION_PAGE_URL] => /articles/#SECTION_CODE#/ [CANONICAL_PAGE_URL] => [~CANONICAL_PAGE_URL] => [PICTURE] => [~PICTURE] => [DESCRIPTION] => Статьи [~DESCRIPTION] => Статьи [DESCRIPTION_TYPE] => html [~DESCRIPTION_TYPE] => html [RSS_TTL] => 24 [~RSS_TTL] => 24 [RSS_ACTIVE] => Y [~RSS_ACTIVE] => Y [RSS_FILE_ACTIVE] => N [~RSS_FILE_ACTIVE] => N [RSS_FILE_LIMIT] => [~RSS_FILE_LIMIT] => [RSS_FILE_DAYS] => [~RSS_FILE_DAYS] => [RSS_YANDEX_ACTIVE] => N [~RSS_YANDEX_ACTIVE] => N [XML_ID] => content-articles [~XML_ID] => content-articles [TMP_ID] => 79a4a50658ff380feeea3c1c690acaa8 [~TMP_ID] => 79a4a50658ff380feeea3c1c690acaa8 [INDEX_ELEMENT] => Y [~INDEX_ELEMENT] => Y [INDEX_SECTION] => Y [~INDEX_SECTION] => Y [WORKFLOW] => N [~WORKFLOW] => N [BIZPROC] => N [~BIZPROC] => N [SECTION_CHOOSER] => L [~SECTION_CHOOSER] => L [LIST_MODE] => [~LIST_MODE] => [RIGHTS_MODE] => S [~RIGHTS_MODE] => S [SECTION_PROPERTY] => Y [~SECTION_PROPERTY] => Y [PROPERTY_INDEX] => I [~PROPERTY_INDEX] => I [VERSION] => 1 [~VERSION] => 1 [LAST_CONV_ELEMENT] => 0 [~LAST_CONV_ELEMENT] => 0 [SOCNET_GROUP_ID] => [~SOCNET_GROUP_ID] => [EDIT_FILE_BEFORE] => [~EDIT_FILE_BEFORE] => [EDIT_FILE_AFTER] => [~EDIT_FILE_AFTER] => [SECTIONS_NAME] => Разделы статей [~SECTIONS_NAME] => Разделы статей [SECTION_NAME] => Раздел статей [~SECTION_NAME] => Раздел статей [ELEMENTS_NAME] => Статьи [~ELEMENTS_NAME] => Статьи [ELEMENT_NAME] => Статья [~ELEMENT_NAME] => Статья [REST_ON] => N [~REST_ON] => N [EXTERNAL_ID] => content-articles [~EXTERNAL_ID] => content-articles [LANG_DIR] => / [~LANG_DIR] => / [SERVER_NAME] => sepsisforum.ru [~SERVER_NAME] => sepsisforum.ru ) [SECTION] => Array ( [PATH] => Array ( ) ) [SECTION_URL] => [META_TAGS] => Array ( [TITLE] => Запись вебинара от 14 мая «Особенности антимикробной терапии нозокомиальных инфекций в онкологии» [BROWSER_TITLE] => [KEYWORDS] => [DESCRIPTION] => ) )
Инфекции представляют серьезную угрозу как жизни одного человека, так и человечеству в целом. Открытие антибиотиков позволило спасти миллионы людей. Вместе с тем, широкое применение АБ препаратов привело к формированию устойчивости к ним у целого ряда микроорганизмов.
Антибиотикорезистентность в настоящий момент приобрела глобальный характер . Во время вебинара были представлены проблемы терапии инфекций у одной из наиболее сложных категорий больных- онкологических. Були показаны особенности инфекций у этой категории пациентов, принципы управления антимикробной резистентностью в стационаре, возможности современных АБ препаратов и их правильное использование.
Вебинар предназначен для широкой аудитории врачей- клинических фармакологов, реаниматологов, онкологов, хирургов, терапевтов.
Модераторы вебинара:
Кулабухов Владимир Витальевич - ведущий научный сотрудник ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ» к.м.н., доцент
Епифанова Наталья Юрьевна - доктор медицинских наук, заведующая отделением клинической фармакологии «Национального медицинского исследовательского центра онкологии им Н.Н. Блохина»
Вебинар проходил 14 мая в 15:00
Свои вопросы вы сможете задать, направив их по адресу vkulabukhov@me.com
Посмотреть запись Вы можете по ссылке: https://youtu.be/-317GjkyEUA
Необходимо Войти или Создать аккаунт
Инфекции представляют серьезную угрозу как жизни одного человека, так и человечеству в целом. Открытие антибиотиков позволило спасти миллионы людей. Вместе с тем, широкое применение АБ препаратов привело к формированию устойчивости к ним у целого ряда микроорганизмов.
Антибиотикорезистентность в настоящий момент приобрела глобальный характер . Во время вебинара были представлены проблемы терапии инфекций у одной из наиболее сложных категорий больных- онкологических. Були показаны особенности инфекций у этой категории пациентов, принципы управления антимикробной резистентностью в стационаре, возможности современных АБ препаратов и их правильное использование.
Вебинар предназначен для широкой аудитории врачей- клинических фармакологов, реаниматологов, онкологов, хирургов, терапевтов.
Модераторы вебинара:
Кулабухов Владимир Витальевич - ведущий научный сотрудник ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ» к.м.н., доцент
Епифанова Наталья Юрьевна - доктор медицинских наук, заведующая отделением клинической фармакологии «Национального медицинского исследовательского центра онкологии им Н.Н. Блохина»
Вебинар проходил 14 мая в 15:00
Свои вопросы вы сможете задать, направив их по адресу vkulabukhov@me.com
Посмотреть запись Вы можете по ссылке: https://youtu.be/-317GjkyEUA